Rui Tada
Overview
Explore the profile of Rui Tada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanno T, Tada R, Nakasone T, Okamatsu S, Iwakura Y, Tamura K, et al.
Int J Med Mushrooms
. 2024 Dec;
26(12):1-10.
PMID: 39704615
The traditional use of Cordyceps militaris, an entomopathogenic fungus, in East Asian medicine has been well documented. Our previous study revealed that the fruiting body powder of C. militaris, referred...
2.
Kanno T, Tada R, Nakasone T, Okamatsu S, Iwakura Y, Tamura K, et al.
Mol Immunol
. 2024 Sep;
175:112-120.
PMID: 39341081
Cordyceps militaris, an entomopathogenic fungus, has been traditionally used in East Asian medicine. Recent research indicates that the fruit bodies of C. militaris are rich in bioactive compounds, such as...
3.
Tada R, Ito H, Nagai Y, Sakurai Y, Yamanaka D, Ohno N, et al.
Int J Med Mushrooms
. 2024 Aug;
26(10):1-8.
PMID: 39171627
Mucosal vaccination is a promising strategy for combating infectious diseases caused by pathogenic microbes, as it can generate antigen-specific immune responses in both systemic and mucosal compartments. In our recent...
4.
Tada R, Nagai Y, Ogasawara M, Saito M, Ohshima A, Yamanaka D, et al.
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793700
The development of mucosal vaccines, which can generate antigen-specific immune responses in both the systemic and mucosal compartments, has been recognized as an effective strategy for combating infectious diseases caused...
5.
Yano Y, Tada R, Hamano N, Haruta K, Kobayashi T, Sato M, et al.
J Immunol Methods
. 2023 Sep;
521:113554.
PMID: 37661049
Antibodies are essential components of the immune system with a wide range of molecular targets. They have been recognized as modalities for treating several diseases and more than 130 approved...
6.
Sekine S, Mayama S, Nishijima N, Kojima T, Endo-Takahashi Y, Ishii Y, et al.
Pharmaceutics
. 2023 Jun;
15(6).
PMID: 37376113
Strategies for gene and nucleic acid delivery to skeletal muscles have been extensively explored to treat Duchenne muscular dystrophy (DMD) and other neuromuscular diseases. Of these, effective intravascular delivery of...
7.
Tada R, Ohno N, Adachi Y
Carbohydr Res
. 2023 May;
529:108849.
PMID: 37216698
OL-2 is a water-soluble β-glucan produced by Omphalia lapidescens. This versatile glucan has potential applications in various industries, including food, cosmetics, and pharmaceuticals. In addition, OL-2 is known for its...
8.
Tada R, Yamazaki H, Nagai Y, Takeda Y, Ohshima A, Kunisawa J, et al.
Int Immunopharmacol
. 2023 May;
119:110262.
PMID: 37150015
The coronavirus disease 2019, i.e., the COVID-19 pandemic, caused by a highly virulent and transmissible pathogen, has profoundly impacted global society. One approach to combat infectious diseases caused by pathogenic...
9.
Adachi Y, Momose F, Momose H, Tada R, Ohno N
Int J Med Mushrooms
. 2023 Apr;
25(3):1-19.
PMID: 37017658
β-glucans are polysaccharides that activate innate immunity. We herein investigated whether P-glucans promote the immunological effects of antibody drugs against malignant tumor cells using human peripheral blood mononuclear cells (PBMCs)....
10.
Yano Y, Hamano N, Haruta K, Kobayashi T, Sato M, Kikkawa Y, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678759
A key challenge in treating solid tumors is that the tumor microenvironment often inhibits the penetration of therapeutic antibodies into the tumor, leading to reduced therapeutic efficiency. It has been...